Estrogen Reduces Lipid Content in the Liver Exclusively from Membrane Receptor Signaling
Estrogen Reduces Lipid Content in the Liver Exclusively from Membrane Receptor Signaling
复制标题
DOI:
10.1126/scisignal.2004013
复制
发表时间:
2013-05-21
影响因子:
7.3
通讯作者:
Levin, Ellis R.
中科院分区:
文献类型:
--
作者:
Pedram, Ali;Razandi, Mahnaz;Levin, Ellis R.
Estrogen induces signal transduction through estrogen receptor alpha (ER alpha), which localizes to both the plasma membrane and nucleus. Using wild-type mice, ER alpha knockout (ERKO) mice, or transgenic mice expressing only the ligand-binding domain of ER alpha exclusively at the plasma membrane (MOER), we compared the transcriptional profiles of liver tissue extracts after mice were injected with the ERa agonist propyl-pyrazole-triol (PPT). The expression of many lipid synthesis-related genes was comparably decreased in livers from MOER or wild-type mice but was not suppressed in ERKO mice, indicating that only membrane-localized ER alpha was necessary for their suppression. Cholesterol, triglyceride, and fatty acid content was decreased only in livers from wild-type and MOER mice exposed to PPT, but not in the livers from the ERKO mice, validating the membrane-driven signaling pathway on a physiological level. PPT-triggered activation of ER alpha at the membrane induced adenosine monophosphate-activated protein kinase to phosphorylate sterol regulatory element-binding factor 1 (Srebf1), preventing its association with and therefore its proteolytic cleavage by site-1 protease. Consequently, Srebf1 was sequestered in the cytoplasm, preventing the expression of cholesterol synthesis-associated genes. Thus, we showed that inhibition of gene expression mediated by membrane-localized ER alpha caused a metabolic phenotype that did not require nuclear ER alpha.